Cummins Strategy Partners

CSP acts as strategic bridge between Pharma/Biotech companies and complex fragmented European commercial landscape. CSP combines deep local expertise with flexible partnership support enabling companies to establish early presence and prepare for successful launch without heavy upfront  investment or infrastructure. 

​

What we offer?

​

Lean, Senior Expertise 

Every engagement led by senior executives with proven EU rare disease orphan and speciality experience.

Plug-and-Play Infrastructure

Network of regulatory, distribution, and market access partners across the EU.

Flexible Engagement

Fractional, project-based, or retained support aligned to US biotech timelines and budgets.

Patient-Focused Ethos

Ensures programmes deliver value ethically and transparently for patients and payers.

Proven Track Record

Experience drawn from multiple major global rare-disease launches.